Breast Cancer Steering Committee Roster
The Breast Cancer Steering Committee (BCSC) addresses the design, prioritization, and evaluation of concepts for phase 2, 2/3, and 3 clinical trials in adult breast cancer. Committee activities help foster collaboration between groups and institutions engaged in conducting trials. The BCSC's membership comprises NCTN group representatives, community oncologists, Specialized Programs of Research Excellence (SPORE) representatives, biostatisticians, patient advocates, subject matter experts, and NCI staff.
Co-chairs
Shelley Hwang, M.D., M.P.H.
Duke University Medical Center
Durham, NC
Antonio C. Wolff, M.D., FACP, FASCO
Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center
Baltimore, MD
Kathy D. Miller, M.D. [Chair Emeritus]
Indiana University Simon Cancer Center
Indianapolis, IN
Members
Vandana Abramson, M.D.
Vanderbilt University Ingram Cancer Center
Nashville, TN
Sunil Badve, M.B.B.S., M.D., FRCPath.
Emory University School of Medicine
Atlanta, GA
Karla Ballman, Ph.D.
Mayo Clinic
Rochester, MN
Lisa Carey, M.D.
University of North Carolina Lineberger Comprehensive Cancer Center
Chapel Hill, NC
Stephen Chia, M.D.
British Columbia Cancer Agency
Vancouver, BC, Canada
Angela DeMichele, M.D., M.S.C.E.
University of Pennsylvania Perelman Center for Advanced Medicine
Philadelphia, PA
Jared Foster, Ph.D.
National Cancer Institute
Bethesda, MD
Jami Fukui, M.D.
University of Hawai'i Cancer Center
Honolulu, HI
Elizabeth Garrett-Mayer, PhD
American Society of Clinical Oncology
Alexandria, VA
Lisa R. Hayes, J.D.
Pink-4-Ever Ending Disparities
Indianapolis, IN
Larissa Korde, M.D., M.P.H.
National Cancer Institute
Bethesda, MD
Amy K. Krie, M.D.
Allina Health Cancer Institute
Minneapolis, MN
Stanley Lipkowitz, M.D., Ph.D.
National Cancer Institute
Bethesda, MD
Eleftherios P. Mamounas, M.D., M.P.H.
University of Florida Health Cancer Center
Orlando, FL
Ben Ho Park, M.D., Ph.D.
Vanderbilt University Ingram Cancer Center
Nashville, TN
Ann H. Partridge, M.D., M.P.H.
Dana-Farber Cancer Institute
Boston, MA
Lajos Pusztai, M.D., D.Phil.
Yale University
New Haven, CT
Eileen Rakovitch, M.D., M.Sc.
Sunnybrook Health Sciences Centre
Toronto, ON, Canada
Kathryn Ruddy, M.D.
Mayo Clinic
Rochester, MN
Bryan Schneider, M.D.
Indiana University Simon Cancer Center
Indianapolis, IN
Priyanka Sharma, M.D.
University of Kansas Medical Center
Westwood, KS
Mary Lou Smith, J.D., M.B.A.
Research Advocacy Network
Plano, TX
Sara Tolaney, M.D., M.P.H.
Dana-Farber Cancer Institute
Boston, MA
Julia White, M.D.
The University of Kansas Cancer Center
Kansas City, KS
Richard C. Zellars, M.D.
Indiana University
Indianapolis, IN
Fengmin Zhao, Ph.D., M.H.S.
Harvard University Medical School
Boston, MA
NCI CCCT Program Director
Elena Schwartz, Ph.D.
elena.schwartz@nih.gov